# Ginkgo Biloba Extract and the Insulin Resistance Syndrome

> **NCT00032474** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 150 (—)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Ginkgo biloba extract

## Key facts

- **NCT ID:** NCT00032474
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 150 (—)
- **Last updated:** 2006-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032474, "Ginkgo Biloba Extract and the Insulin Resistance Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00032474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*